Are prognostic factors in rheumatoid arthritis of any use in daily clinical practice?

Free article

Editorial

P van Riel. Neth J Med. 2002 Nov.

Free article

. 2002 Nov;60(10):381-2.

No abstract available

Comment on

Anticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis.
van Venrooij WJ, Hazes JM, Visser H. van Venrooij WJ, et al. Neth J Med. 2002 Nov;60(10):383-8. Neth J Med. 2002. PMID: 12607587 Review. No abstract available.

Anticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis.
van Venrooij WJ, Hazes JM, Visser H. van Venrooij WJ, et al. Neth J Med. 2002 Nov;60(10):383-8. Neth J Med. 2002. PMID: 12607587 Review. No abstract available.
Use and significance of anti-CCP autoantibodies in rheumatoid arthritis.
Zendman AJ, van Venrooij WJ, Pruijn GJ. Zendman AJ, et al. Rheumatology (Oxford). 2006 Jan;45(1):20-5. doi: 10.1093/rheumatology/kei111. Epub 2005 Sep 27. Rheumatology (Oxford). 2006. PMID: 16188946 Review. No abstract available.
[Usefulness of anti-citrullinated protein antibodies in the diagnosis and prognosis of rheumatoid arthritis].
Bas S. Bas S. Rev Med Suisse. 2005 Mar 9;1(10):674, 677-8, 680 passim. Rev Med Suisse. 2005. PMID: 15828370 Review. French.
[An update on diagnostic and prognostic biomarkers of early rheumatoid arthritis].
Senolt L. Senolt L. Cas Lek Cesk. 2006;145(7):538-42; discussion 542-3. Cas Lek Cesk. 2006. PMID: 16921781 Review. Czech.
[Anti-citrullinated peptide antibodies: novel markers for rheumatoid polyarthritis].
Yalaoui S. Yalaoui S. Arch Inst Pasteur Tunis. 2006;83(1-4):13-7. Arch Inst Pasteur Tunis. 2006. PMID: 19388592 Review. French.